IP Library Granted Patent US 9,732,373
Granted Patent B2
US 9,732,373 · App. 14/851,608 · Granted Aug 15, 2017

Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,732,373
App. No.
14/851,608
Granted
Aug 15, 2017
Kind
B2
Abstract

Provided herein are isolated polynucleotide encoding modified click beetle luciferase polypeptides that have enhanced luminescence and longer wavelength near-infrared signals. The disclosure also relates to near-infrared bioluminescence systems that include said modified click beetle luciferase polypeptides and novel luciferin derivatives, as well as methods of using said modified click beetle luciferase polypeptides and bioluminescence systems.

Claims (25)

1. An isolated polynucleotide encoding a click beetle red luciferase (CBR) variant polypeptide having at least 80% amino acid sequence identity to SEQ ID NO: 1 and comprising an amino acid substitution at a position corresponding to positions 389, 444, and 251 of SEQ ID NO: 1, or an amino acid substitution at a position corresponding to positions 334 and 351 of SEQ ID NO: 1, wherein the variant CBR polypeptide has at least one of enhanced luminescence, altered light emission wavelength, altered substrate specificity, or a combination thereof, as compared to a CBR polypeptide of SEQ ID NO: 1.

2. The isolated polynucleotide of claim 1 , wherein the CBR variant polypeptide further comprises an amino acid substitution at a position corresponding to positions 51 and 444 of SEQ ID NO:1.

3. The isolated polynucleotide of claim 2 , wherein the amino acid substitutions comprise S51N and S444R.

4. The isolated polynucleotide of claim 1 , wherein the CBR variant polypeptide further comprises a substitution corresponding to at least one of R4H, H16Q, H34Y, D47E, S51N, Y52C, F55L/V, K72E, 179V, M73K/T, N74S, E82G, N83H, F87S, I89V, V104D, I109N/V, L113Q, M117T, I119F/T, I124V, N130K, 1131N/T, N133D, L136N, F144L, K146E, N156D, N156K, G159D, Y170C, K179S, V186A, H218L/Y, G225S, T226C/G/H/N/Q/Y, L228P, I229V, V234A, Y252C, V255D/F, F253K, R280S, S281N/Q, V285A, L309T, E319G, N329D, C3353, F337E, I346N, Q348H/E, L350P, D352N, K355G, S358P, T363A/S, I370T, K3901, M393K/L, V394M, N400D, N401S, I409T, D412G, Y422C, V431A, E437G, I439V, Q445H, E453K, L455D, K457N, D471V, E473A, S479T, K484E/M/R, E489V, Y496H, E501G, V503M, Y508C, V516A, T528A, E531G, Q535H, L537W, K539R, or combinations thereof, of SEQ ID NO: 1.

5. The isolated polynucleotide of claim 1 , wherein the amino acid substitutions comprise 1389F, S444R, and G251S.

6. The isolated polynucleotide of claim 1 , wherein the amino acid substitutions comprise R334S and G351R.

7. The isolated polynucleotide of claim 1 , wherein the sequence has been codon-optimized.

8. The isolated polynucleotide of claim 1 , wherein the polynucleotide further encodes a polypeptide of interest linked to the CBR variant polypeptide, the polypeptide of interest and the CBR variant polypeptide capable of being expressed as a fusion protein.

9. An isolated polynucleotide encoding a click beetle red luciferase (CBR) variant polypeptide comprising a polypeptide sequence of SEQ ID NO: 2, SEQ ID NO: 3, or SEQ ID NO: 4, wherein the variant CBR polypeptide has at least one of enhanced luminescence, altered light emission wavelength, altered substrate specificity, or a combination thereof, as compared to a CBR polypeptide of SEQ ID NO: 1.

10. A vector comprising the polynucleotide of claim 1 .

11. The vector of claim 10 , wherein the polynucleotide is operably linked to a promoter.

12. A cell comprising the polynucleotide of claim 1 .

13. A kit comprising the polynucleotide of claim 1 .

14. The kit of claim 13 further comprising at least one of:

(a)

and

(b) a buffer reagent.

15. A CBR variant polypeptide encoded by the polynucleotide of claim 1 .

16. A circularly permuted luciferase comprising the CBR variant polypeptide of claim 15 .

17. A fusion protein comprising a CBR variant polypeptide encoded by the polynucleotide of claim 1 .

18. A near-infrared bioluminescence system comprising the CBR variant polypeptide of claim 15 and a luciferin derivative.

19. A kit comprising the CBR variant polypeptide of claim 15 and at least one of:

(a)

and

(b) a buffer reagent.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2015
From: ENCELL, LANCE P.; HALL, MARY P.; WOOD, KEITH V.; WOOD, MONIKA G.
To: PROMEGA CORPORATION
Reel/Frame 036678/0092 →